| Current prevalence and incidence of infectious disease markers and estimated window‐period risk in the American Red Cross blood donor population RY Dodd, EP Notari IV, SL Stramer Transfusion 42 (8), 975-979, 2002 | 858 | 2002 |
| Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States EM Lackritz, GA Satten, J Aberle-Grasse, RY Dodd, VP Raimondi, ... New England Journal of Medicine 333 (26), 1721-1725, 1995 | 498 | 1995 |
| Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic … S Zou, KA Dorsey, EP Notari, GA Foster, DE Krysztof, F Musavi, RY Dodd, ... Transfusion 50 (7), 1495-1504, 2010 | 380 | 2010 |
| International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009 WK Roth, MP Busch, A Schuller, S Ismay, A Cheng, CR Seed, ... Vox Sanguinis 102 (1), 82-90, 2012 | 283 | 2012 |
| Transfusion‐related acute lung injury surveillance (2003‐2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross AF Eder, R Herron, A Strupp, B Dy, EP Notari, LA Chambers, RY Dodd, ... Transfusion 47 (4), 599-607, 2007 | 281 | 2007 |
| Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions: the American Red Cross experience (2004‐2006) AF Eder, JM Kennedy, BA Dy, EP Notari, JW Weiss, CT Fang, S Wagner, ... Transfusion 47 (7), 1134-1142, 2007 | 264 | 2007 |
| Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006 S Zou, F Musavi, EP Notari, JA Rios, J Trouern‐Trend, CT Fang Transfusion 48 (12), 2531-2539, 2008 | 208 | 2008 |
| Adverse reactions to allogeneic whole blood donation by 16-and 17-year-olds AF Eder, CD Hillyer, BA Dy, EP Notari, RJ Benjamin Jama 299 (19), 2279-2286, 2008 | 202 | 2008 |
| Effective reduction of transfusion‐related acute lung injury risk with male‐predominant plasma strategy in the American Red Cross (2006‐2008) AF Eder, RM Herron Jr, A Strupp, B Dy, J White, EP Notari, RY Dodd, ... Transfusion 50 (8), 1732-1742, 2010 | 192 | 2010 |
| Estimated US infection-and vaccine-induced SARS-CoV-2 seroprevalence based on blood donations, July 2020-May 2021 JM Jones, M Stone, H Sulaeman, RV Fink, H Dave, ME Levy, ... Jama 326 (14), 1400-1409, 2021 | 186 | 2021 |
| The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006 AF Eder, BA Dy, JM Kennedy, EP Notari IV, A Strupp, ME Wissel, R Reddy, ... Transfusion 48 (9), 1809-1819, 2008 | 173 | 2008 |
| Current incidence and residual risk of hepatitis B infection among blood donors in the United States S Zou, SL Stramer, EP Notari, MC Kuhns, D Krysztof, F Musavi, CT Fang, ... Transfusion 49 (8), 1609-1620, 2009 | 165 | 2009 |
| Changing age distribution of the blood donor population in the United States S Zou, F Musavi, EP Notari IV, CT Fang, ARCNET Research Group Transfusion 48 (2), 251-257, 2008 | 155 | 2008 |
| Limiting and detecting bacterial contamination of apheresis platelets: inlet‐line diversion and increased culture volume improve component safety AF Eder, JM Kennedy, BA Dy, EP Notari, R Skeate, G Bachowski, DC Mair, ... Transfusion 49 (8), 1554-1563, 2009 | 142 | 2009 |
| Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? SL Stramer, EP Notari, DE Krysztof, RY Dodd Transfusion 53 (10pt2), 2449-2458, 2013 | 134 | 2013 |
| Patterns of age‐and sex‐specific prevalence of major blood‐borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study S Zou, EP Notari IV, SL Stramer, F Wahab, F Musavi, RY Dodd, ... Transfusion 44 (11), 1640-1647, 2004 | 96 | 2004 |
| Age‐related donor return patterns among first‐time blood donors in the United States EP Notari IV, S Zou, CT Fang, AF Eder, RJ Benjamin, RY Dodd Transfusion 49 (10), 2229-2236, 2009 | 94 | 2009 |
| Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value? SL Stramer, S Zou, EP Notari, GA Foster, DE Krysztof, F Musavi, RY Dodd Transfusion 52 (2), 440-446, 2012 | 87 | 2012 |
| Screening blood donors for HIV, HCV, and HBV at the American Red Cross: 10-year trends in prevalence, incidence, and residual risk, 2007 to 2016 RY Dodd, LA Crowder, JM Haynes, EP Notari, SL Stramer, WR Steele Transfusion Medicine Reviews 34 (2), 81-93, 2020 | 63 | 2020 |
| Seroprevalence of known and putative hepatitis markers inUnited States blood donors with ALT levels at least 120 IU per L EP Notari IV, SL Orton, RG Cable, AJ Grindon, BA Lenes, AE Williams, ... Transfusion 41 (6), 751-755, 2001 | 61 | 2001 |
